Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Autor: Chen, Robert, Palmer, Joycelynne M., Martin, Peter, Tsai, Nicole, Kim, Young, Chen, Bihong T., Popplewell, Leslie, Siddiqi, Tanya, Thomas, Sandra H., Mott, Michelle, Sahebi, Firoozeh, Armenian, Saro, Leonard, John, Nademanee, Auayporn, Forman, Stephen J.
Zdroj: In Biology of Blood and Marrow Transplantation December 2015 21(12):2136-2140
Databáze: ScienceDirect
Externí odkaz: